Published in Thromb Res on December 16, 2011
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med (2016) 0.76
Hypernephroma presenting with cutaneous leukocytoclastic vasculitis and lupus anticoagulant: resolution after nephrectomy. Case Rep Urol (2012) 0.75
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol (2005) 9.67
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J (2006) 3.95
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine (2006) 2.78
[Not Available]. Tidsskr Nor Laegeforen (2016) 1.92
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood (2010) 1.91
Perioperative management of oral anticoagulant therapy. Thromb Res (2002) 1.62
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood (2003) 1.50
Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis. J Vasc Interv Radiol (2012) 1.46
Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol (2003) 1.40
[Anti-reflux surgery in Norway]. Tidsskr Nor Laegeforen (2005) 1.40
[New guidelines for antithrombotic therapy and thromboprophylaxis]. Tidsskr Nor Laegeforen (2014) 1.40
New oral anticoagulants--a review. Tidsskr Nor Laegeforen (2013) 1.39
[Analysis of prothrombin time in primary health care]. Tidsskr Nor Laegeforen (2005) 1.38
Incidence of obstetric anal sphincter injuries after training to protect the perineum: cohort study. BMJ Open (2012) 1.34
Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol (2007) 1.26
The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol (2003) 1.22
Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand (2012) 1.20
Infection after primary hip arthroplasty: a comparison of 3 Norwegian health registers. Acta Orthop (2011) 1.14
Chlamydia trachomatis infections increase the risk for ectopic pregnancy: a population-based, nested case-control study. Sex Transm Dis (2007) 1.03
Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway. Int J Cancer (2002) 1.03
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771). Am Heart J (2007) 1.02
Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. MAGMA (2004) 1.00
Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis (2007) 1.00
Classification of stillbirths and risk factors by cause of death--a case-control study. Acta Obstet Gynecol Scand (2013) 1.00
Deep vein thrombosis after elective cesarean section. Thromb Res (2004) 0.97
Chlamydia trachomatis testing patterns and prevalence of genital chlamydial infection among young men and women in central Norway 1990-2003: a population-based registry study. Sex Transm Dis (2006) 0.93
Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study. BMJ Open (2013) 0.92
Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA). J Magn Reson Imaging (2010) 0.92
Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women. Sex Transm Dis (2011) 0.92
Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility. BMC Cancer (2011) 0.90
Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Thromb Res (2009) 0.90
Prevalence and risk factors for anal incontinence after obstetric anal sphincter rupture. Acta Obstet Gynecol Scand (2011) 0.89
[Reduced number of extrauterine pregnancies--increased fertility of women during the 1990s?]. Tidsskr Nor Laegeforen (2003) 0.89
Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor. Thromb Haemost (2008) 0.88
Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. Br J Haematol (2002) 0.88
Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis. Thromb Res (2009) 0.88
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study. BMJ Open (2013) 0.87
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity. J Hematol Oncol (2013) 0.87
Pain and quality of life among long-term gynecological cancer survivors: a population-based case-control study. Acta Obstet Gynecol Scand (2007) 0.86
Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era. J Public Health (Oxf) (2012) 0.85
[Chlamydia trachomatis--pattern of testing and prevalence among young women]. Tidsskr Nor Laegeforen (2004) 0.85
Chlamydia trachomatis among young Norwegian men: sexual behavior and genitourinary symptoms. Sex Transm Dis (2007) 0.85
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas (2005) 0.85
Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire. Scand J Caring Sci (2008) 0.84
Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells. Mol Carcinog (2010) 0.84
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI. Thromb Haemost (2013) 0.84
Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study. BMJ Open (2012) 0.84
Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP). Thromb Haemost (2014) 0.83
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process. Chest (2014) 0.83
Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study. BMC Pregnancy Childbirth (2012) 0.83
Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke (2012) 0.83
[Chlamydia infections and sexual behavior among young women]. Tidsskr Nor Laegeforen (2004) 0.83
[Cholecystectomy in Norway 1990-2002]. Tidsskr Nor Laegeforen (2004) 0.82
Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome. Acta Obstet Gynecol Scand (2003) 0.82
Risks for peroperative excessive blood loss in cesarean delivery. Acta Obstet Gynecol Scand (2010) 0.82
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia. Semin Thromb Hemost (2011) 0.82
Functional characterization of polymorphisms in the human TFPI gene. Biochem Biophys Res Commun (2010) 0.81
Socioeconomic conditions and number of pain sites in women. BMC Womens Health (2012) 0.81
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev (2014) 0.81
Venous thromboembolism associated with pregnancy and hormonal therapy. Best Pract Res Clin Haematol (2012) 0.81
Use of IUD and subsequent fertility--follow-up after participation in a randomized clinical trial. Contraception (2006) 0.81
Protein C mutation (A267T) results in ER retention and unfolded protein response activation. PLoS One (2011) 0.81
Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport. BMC Cell Biol (2010) 0.81
Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovasc Disord (2006) 0.81
Importance of specimen type in detecting human papillomavirus DNA from the female genital tract. J Med Virol (2009) 0.80
Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. BJOG (2003) 0.80
Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagul Fibrinolysis (2011) 0.80
Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. J Clin Virol (2006) 0.80
TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells. PLoS One (2012) 0.80
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]. Tidsskr Nor Laegeforen (2008) 0.79
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thromb Res (2006) 0.79
[Testing pattern and prevalence of Chlamydia infections among men]. Tidsskr Nor Laegeforen (2005) 0.79
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. Br J Haematol (2011) 0.79
[Testing pattern and prevalence of Chlamydia infection among women]. Tidsskr Nor Laegeforen (2005) 0.79
Incidence and risk factors of fetal death in Norway: a case-control study. Acta Obstet Gynecol Scand (2011) 0.79
Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort. Qual Life Res (2014) 0.79
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thromb Res (2012) 0.79
Methodology of the Norwegian Surveillance System for Healthcare-Associated Infections: the value of a mandatory system, automated data collection, and active postdischarge surveillance. Am J Infect Control (2013) 0.79
Adolescents: is there an association between knowledge of oral contraceptives and profession of provider? Eur J Contracept Reprod Health Care (2007) 0.79
Prevalence and Risk Indicators for Anal Incontinence among Pregnant Women. ISRN Obstet Gynecol (2013) 0.78
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants. Br J Haematol (2006) 0.78
[Little knowledge about human papillomavirus among young Norwegian women]. Tidsskr Nor Laegeforen (2006) 0.78
Guidelines for antibiotic prophylaxis of cholecystectomies in Norwegian hospitals. Surg Infect (Larchmt) (2013) 0.78
HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology. Curr Pharm Des (2013) 0.78